Release Date: 01/08/11 09:15 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 880.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%